Performance of GSK GlaxoSmithKline PLC ADR | 27.7% in 12m

Compare GSK with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare GlaxoSmithKline PLC ADR with its related Sector/Index XLV

Compare GlaxoSmithKline PLC ADR with its related Sector/Index XLV

Performance Duell GSK vs XLV

TimeFrame GSK XLV
1 Day 0.47% 1.33%
1 Week 2.53% 1.55%
1 Month 1.44% 1.02%
3 Months 17.0% 9.09%
6 Months 18.4% 15.34%
12 Months 27.7% 17.46%
YTD 15.7% 6.82%
Rel. Perf. 1m 0.11
Rel. Perf. 3m 0.79
Rel. Perf. 6m 0.27
Rel. Perf. 12m 0.82

Is GlaxoSmithKline PLC ADR a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, GlaxoSmithKline PLC ADR (NYSE:GSK) is currently (March 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 3.72 and therefor a somewhat positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSK as of March 2024 is 40.66. This means that GSK is currently overvalued and has a potential downside of -5.42%.

Is GSK a buy, sell or hold?

  • Strong Buy: 2
  • Buy: 1
  • Hold: 4
  • Sell: 1
  • Strong Sell: 0
GlaxoSmithKline PLC ADR has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold GSK.
Values above 0%: GSK is performing better - Values below 0%: GSK is underperforming

Compare GSK with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 2.01% -2.08% -5.31% -6.21%
US NASDAQ 100 QQQ 2.29% -0.35% -7.40% -17.38%
US Dow Jones Industrial 30 DIA 1.88% -0.83% -1.27% 2.69%
German DAX 40 DBXD -0.08% -3.85% -3.06% 6.15%
UK FTSE 100 ISFU 0.69% -1.83% 7.98% 14.41%
Shanghai Shenzhen CSI 300 CSI 300 5.57% 1.69% 23.35% 43.50%
Hongkong Hang Seng HSI 4.96% 6.76% 24.31% 47.45%
Japan Nikkei 225 EXX7 1.34% -1.39% -2.48% -0.02%
India NIFTY 50 INDA 1.20% 2.49% 3.79% -4.79%
Brasil Bovespa EWZ 3.47% 6.05% 6.39% -4.61%

GSK GlaxoSmithKline PLC ADR vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 2.32% -2.11% -7.68% -18.90%
Consumer Discretionary XLY 1.88% 0.12% 1.43% -3.38%
Consumer Staples XLP 2.15% -1.69% 5.86% 20.66%
Energy XLE 1.06% -8.18% 15.21% 6.18%
Financial XLF 1.74% -3.13% -8.75% -8.05%
Health Care XLV 0.98% 0.42% 3.03% 10.19%
Industrial XLI 1.30% -3.64% -6.79% -3.39%
Materials XLB 1.35% -5.88% -1.91% 5.47%
Real Estate XLRE 1.63% -1.79% -0.58% 12.70%
Technology XLK 2.99% -0.21% -10.79% -17.64%
Utilities XLU 0.45% -4.78% 8.01% 25.11%
Aerospace & Defense XAR 1.65% -1.85% -7.81% 3.92%
Biotech XBI 2.79% 9.20% -9.92% 0.99%
Homebuilder XHB 0.49% -6.83% -27.48% -43.21%
Retail XRT 1.20% -1.01% -14.56% -3.94%

GSK GlaxoSmithKline PLC ADR vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 2.19% -3.52% 24.87% 6.82%
Natural Gas UNG 9.17% 12.70% 64.98% 76.91%
Gold GLD 2.07% -6.59% 1.71% 16.03%
Silver SLV 5.88% -7.99% 9.63% 21.57%
Copper CPER 4.41% -3.02% 7.04% 27.37%

Returns of GSK vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.58% -0.78% 9.17% 33.61%
iShares High Yield Corp. Bond HYG 2.43% 0.53% 9.05% 15.08%
Does GlaxoSmithKline PLC ADR outperform its market, is GSK a Sector Leader?
Yes, over the last 12 months GlaxoSmithKline PLC ADR (GSK) made 27.65%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.46%.
Over the last 3 months GSK made 17.01%, while XLV made 9.09%.
Period GSK XLV S&P 500
1 Month 1.44% 1.02% 3.52%
3 Months 17.01% 9.09% 10.13%
12 Months 27.65% 17.46% 33.86%